Randomized controlled trialHumanClinical Trial, Phase II
Larazotide acetate for persistent symptoms of celiac disease despite a gluten-free diet: a randomized controlled trial
Gastroenterology, 2015 Jun. Leffler DA, Kelly CP, Green PH and 8 others.
Study type
Randomized controlled trial · Clinical Trial, Phase II
Subjects
Human participants (PubMed MeSH: Humans)
Journal
Gastroenterology
Published
2015 Jun
PubMed
Where PepCue cites this
This paper is part of the evidence base behind this profile. Citing a study is not an endorsement of the compound: papers that found no effect are indexed the same way.
Indexed under
MeSH terms assigned by the National Library of Medicine.
AdultCeliac DiseaseCombined Modality TherapyDiet, Gluten-FreeDouble-Blind MethodFemaleGastrointestinal AgentsHumansMaleMiddle AgedNorth AmericaOligopeptides
Other papers on Larazotide
Review · 2021
Current pharmacological approaches and potential future therapies for Celiac disease
Journal article · 2021Larazotide acetate induces recovery of ischemia-injured porcine jejunum via repair of tight junctions
PepCue indexes citation metadata only and does not reproduce abstracts or full text. Read the paper at the source links above. Nothing here is medical advice or a dose recommendation.
Educational and research reference only. Not medical advice, diagnosis, or dosing guidance. Flag an error on this page